The Role of Immune Checkpoint Inhibitors in Brain Metastasis: A Comprehensive Review

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Jameie Melika; A. Basti Fatemeh; Amanollahi Mobina; Heidari Arash

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Immunology and Genetics Journal Year:2025 | Volume:8 | Issue:1 Page(s): 50-94

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

The Role of Immune Checkpoint Inhibitors in Brain Metastasis: A Comprehensive Review

Author(s)

Jameie Melika | A. Basti Fatemeh | Amanollahi Mobina | Heidari Arash | Issue Writer Certificate

Keywords

Anti

1/Anti

Anti

CTLA

Anti

LAG

Brain Metastasis

Immune Checkpoint Inhibitors (ICIs)

Abstract

Brain Metastasis (BM) is a common form of cancer that affects the central nervous system and has a significant impact on the life expectancy and quality of patients. Despite conventional treatments like surgery, chemotherapy, and radiotherapy, managing BM is challenging, and success rates are low. Immune checkpoint inhibitors (ICIs) have emerged as promising new therapies for advanced cancers and work by reversing the immune-evasive characteristics of tumor cells. ICIs have shown efficacy in various malignancies, prompting researchers to evaluate their efficacy in BM. Previously, the exclusion of BM patients from clinical trials was common due to the brain's immune-privileged nature. However, recent studies have demonstrated immune cell trafficking in and out of the brain, leading to several studies investigating the ICIs' application in BM patients. This study aimed to provide further evidence supporting the beneficial effects of ICIs in treating BM, as evidenced by improved response duration and survival time.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans